ReviewClinical ophthalmology (Auckland, N.Z.)2026
Identifying and Managing Pre-Myopia: A Narrative Review.
Review in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Proactive management of children at risk of developing myopia (pre-myopia) can be more impactful than treatment after onset. The aim of this narrative review is to identify risk factors associated with pre-myopia, explore predictors of myopia development in pre-myopic children, and discuss effective prevention strategies. Methods: A comprehensive search was conducted in several databases and clinical trial registries, using keywords related to pre-myopia prevention and control. Results: 266 studies were included. Risk factors associated with pre-myopia development include parental myopia, female gender and insufficient outdoor time. Near work and screen time have a modest link to myopia development, and the role of physical activity remains unclear. Predictive models can categorize children as low, moderate, or high risk of developing myopia. Lifestyle changes, such as increasing outdoor time and limiting near work may be sufficient to stave off myopia onset. Low-dose atropine or myopia control spectacles may be the most effective options for clinicians considering active intervention. Although effective for myopia prevention, repeated low-level red light should be used cautiously in children until its safety profile is better understood. Conclusion: Effective myopia prevention involves managing the hyperopic reserve alongside axial elongation. Behavioural, pharmacological and optical treatments can be effective for preventing myopia, though more evidence is needed before it changes standard practice for pre-myopia management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.